Globalna prevalencija primarnih tumora centralnog nervnog sistema: sistematski pregled i meta-analiza.
European journal of medical research
Sažetak istraživanja
Pozadina Primarni tumori centralnog nervnog sistema (CNS) su heterogena grupa neoplazmi, uključujući benigne i maligne tumore. Budući da postoje mnoge heterogenosti u prevalenciji prijavljenih u prethodnim studijama o ovoj vrsti tumora, ova studija je provedena kako bi se utvrdila ukupna prevalencija različitih primarnih tumora CNS-a. Metoda Studija je provedena kao sistematski pregled i meta-analiza pretraživanjem međunarodnih baza podataka, uključujući PubMed, Scopus, Science Direct, Web of science i Google Scholar tražilicu do avgusta 2020. Nakon prijenosa studija na softver za upravljanje informacijama (EndNote) i eliminacije duplikata studija, preostale studije su pregledane na osnovu kriterija za primarnu inkluziju i tri primarne faze. evaluacija. Softver za sveobuhvatnu meta-analizu, Begg, Mazumdar i I 2 testovi su korišteni za analizu podataka, analizu pristranosti publikacije i analizu heterogenosti, respektivno.
Rezultati Nakon izvođenja koraka sistematskog pregleda, 80 studija je uključeno u konačnu analizu. Na osnovu 8 studija, prevalencija tumora mozga iznosila je 70,9%. Takođe, studije na 7 drugih studija su pokazale da je prevalencija tumora kičme 12,2%. Pregled 14 studija je pokazao da je prevalencija neuroepitelnih tumora bila 34,7%. Analiza 27 studija pokazala je prevalenciju tumora glioma od 42,8%. Analize rađene na drugim studijama pokazale su da je prevalenca adenoma hipofize bila 12,2%, embrionalnih tumora 3,1%, ependimalnih tumora 3,2%, meningioma 24,1%, glijalnih tumora 0,8%, astrocitnih 20,3%, oligodendroglijalnog glioblasta 7,9%, oligodendroglijalnog 7.9% 6,7%, meduloblastom 7,7% i policistični astrocitomi 3,8%.
Zaključak Kao rezultat toga, može se reći da su tumori mozga najčešći tip primarnih tumora CNS-a. Također je uočeno da su tumori koji uključuju neuroepitelne ćelije češći kod pacijenata od drugih vrsta tumora.
Prikaži originalni naslov i sažetak na engleskom
The global prevalence of primary central nervous system tumors: a systematic review and meta-analysis.
Background Primary central nervous system (CNS) tumors are a heterogeneous group of neoplasms, including benign and malignant tumors. Since there are many heterogeneities in the prevalence reported in previous studies on this type of tumor, this study was performed to determine the overall prevalence of different primary CNS tumors.
Method The study was conducted as a systematic review and meta-analysis by searching international databases, including PubMed, Scopus, Science Direct, Web of science, and the Google Scholar search engine until August 2020. After transferring the studies to information management software (EndNote) and eliminating duplicate studies, the remaining studies were reviewed based on inclusion and exclusion criteria according to three stages of primary and secondary evaluation and qualitative evaluation. Comprehensive Meta-Analysis software, Begg, Mazumdar, and I 2 tests were used for data analysis, publication bias analysis, and heterogeneity analysis, respectively.
Results After performing the systematic review steps, 80 studies were included for final analysis. Based on 8 studies, the prevalence of brain tumors was 70.9%. Also, studies on 7 other studies showed that the prevalence of spinal tumors was 12.2%. A review of 14 studies showed that the prevalence of neuroepithelial tumors was 34.7%. The analysis of 27 studies reported a prevalence of glioma tumors of 42.8%. Analyses performed on other studies showed that the prevalence of pituitary adenomas was 12.2%, embryonal tumors 3.1%, ependymal tumors 3.2%, meningiomas 24.1%, glial tumors 0.8%, astrocytic 20.3%, oligodendroglial 3.9%, glioblastoma 17.7%, schwannoma 6.7%, medulloblastoma 7.7% and Polycystic astrocytomas 3.8%.
Conclusion As a result, it can be stated that brain tumors are the most common type of primary CNS tumors. It was also observed that tumors involving neuroepithelial cells are more common in patients than other types of tumors.
Izvorni podaci
- DOI
- 10.1186/s40001-023-01011-y
- PMID
- 36670466
- PMCID
- PMC9854075
- Provjereno
- 2026-07-26
Naslov i sažetak prevedeni su automatski i prijevod može sadržavati netačnosti ili neprecizne stručne izraze. Za sve detalje, citiranje i medicinsko tumačenje pregledajte originalnu englesku verziju članka. Ne donosite zdravstvene odluke samo na osnovu ovog prijevoda.
Pregledaj originalni članak na engleskom